MI Molecular Intelligence Profile Test
Comprehensive Cancer Genomic Profiling for Precision Medicine
The MI Molecular Intelligence Profile Test represents the cutting edge of cancer diagnostics, providing an unprecedented level of molecular insight into tumor biology. This comprehensive genomic analysis combines multiple advanced technologies to deliver a complete molecular portrait of your cancer, enabling oncologists to develop highly personalized treatment strategies based on your tumor’s unique genetic makeup.
What This Advanced Test Measures and Detects
The MI Molecular Intelligence Profile employs a multi-platform approach to analyze cancer at the molecular level:
- Whole Exome Sequencing (NGS DNA): Comprehensive analysis of all protein-coding regions in your genome, identifying mutations across approximately 20,000 genes
- Whole Transcriptome Sequencing (NGS RNA): Examination of gene expression patterns to understand which genes are active in your tumor
- Microsatellite Instability (MSI): Assessment of DNA mismatch repair deficiency, a key biomarker for immunotherapy response
- Tumor Mutational Burden (TMB): Quantification of total mutations in your tumor, predicting response to immunotherapies
- Immunohistochemistry (IHC): Protein expression analysis to validate genetic findings at the protein level
- In Situ Hybridization (ISH): Detection of specific genetic alterations and gene amplifications
Who Should Consider This Comprehensive Cancer Profiling
The MI Molecular Intelligence Profile Test is particularly valuable for patients with:
- Advanced or metastatic cancers requiring targeted treatment options
- Rare cancer types where standard treatment approaches have limited efficacy
- Cancers that have progressed on conventional therapies
- Patients seeking eligibility for clinical trials based on molecular biomarkers
- Complex cancer cases requiring comprehensive molecular characterization
- Patients interested in understanding their immunotherapy response potential
Significant Benefits of Comprehensive Molecular Profiling
This advanced testing approach offers numerous advantages for cancer patients:
- Personalized Treatment Selection: Identify targeted therapies matched to your specific genetic alterations
- Immunotherapy Guidance: Determine likelihood of response to checkpoint inhibitors based on MSI and TMB status
- Clinical Trial Matching: Discover eligibility for cutting-edge treatments and experimental therapies
- Comprehensive Biomarker Analysis: Single test covering multiple biomarker categories rather than sequential testing
- Prognostic Insights: Understand your cancer’s aggressiveness and potential treatment resistance patterns
- Family Risk Assessment: Identify potential hereditary cancer syndromes through germline variant analysis
Understanding Your Test Results
Your comprehensive report will include detailed information about:
- Actionable Mutations: Genetic alterations with approved targeted therapies or clinical trial options
- Biomarker Status: MSI, TMB, and other predictive biomarkers for treatment selection
- Gene Expression Patterns: Insights into tumor biology and potential vulnerabilities
- Therapeutic Recommendations: Evidence-based treatment suggestions based on molecular findings
- Clinical Trial Matches: Specific trials for which you may qualify based on your molecular profile
- Interpretive Guidance: Clear explanations of complex molecular findings for patient understanding
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| MI Molecular Intelligence Profile Test | $16,250 |
| Discounted Price | $14,626 |
Sample Requirements and Processing
For optimal results, please ensure:
- Submit formalin fixed paraffin embedded (FFPE) tissue block
- Ship refrigerated to maintain sample integrity
- Block must contain more than 20% tumor tissue
- Minimum surface area of 25 mm² (5mm x 5mm)
- Complete Tumor Profiling Requisition Form (Form 47)
- Include current histopathology report
- Samples accepted daily by 9:00 AM
- Results delivered in 35 working days
Nationwide Accessibility
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our network ensures accessible molecular diagnostics for patients nationwide.
Take the Next Step Toward Precision Cancer Care
Don’t leave your cancer treatment to chance. The MI Molecular Intelligence Profile Test provides the comprehensive molecular insights needed to make informed treatment decisions. Our team of molecular pathologists and genetic counselors are available to discuss your results and help you understand the implications for your treatment journey.
Ready to unlock the molecular secrets of your cancer? Contact us today to schedule your comprehensive genomic profiling:
Call or WhatsApp: +1(267) 388-9828
Our dedicated patient coordinators will guide you through the testing process, answer your questions about sample requirements, and help you understand how comprehensive molecular profiling can inform your cancer treatment strategy. Take control of your cancer journey with the power of advanced genomic science.
